Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people

Journal of the American Geriatrics Society

Volumn 55, Issue 1, 2007, Pages 20-28

  Sullivan, Dennis H ^a,b   Roberson, Paula K ^c   Smith, Eugene S ^c   Price, J Allen ^a   Bopp, Melinda M ^b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Frail; Megestrol acetate; Muscle strength

Indexed keywords

MEGESTROL ACETATE; PLACEBO;

AGED; ANALYSIS OF COVARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FACTORIAL ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; GERIATRIC CARE; GERIATRIC HOSPITAL; HUMAN; LEG EXERCISE; MALE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE TRAINING; PHYSICAL PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; THIGH; VETERAN;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIET; DIET RECORDS; DOUBLE-BLIND METHOD; EXERCISE THERAPY; FEMALE; FRAIL ELDERLY; HUMANS; MALE; MEGESTROL ACETATE; MUSCLE STRENGTH; MUSCLE, SKELETAL; OUTCOME ASSESSMENT (HEALTH CARE); WEIGHT LIFTING;

EID: 33845964997     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.01010.x     Document Type: Article

References (35)

1. Creditor MC. Hazards of hospitalization of the elderly. Ann Intern Med 1993;118:219-223.
2. Hoenig HM, Rubenstein LZ. Hospital-associated deconditioning and dysfunction. J Am Geriatr Soc 1991;39:220-222.
3. Gill TM, Allore H, Guo Z. The deleterious effects of bed rest among community-living older persons. J Gerontol A Biol Sci Med Sci 2004;59:755-761.
4. Spate U, Schulze PC. Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care 2004;7:265-269.
5. Kotler DP. Cachexia. Ann Intern Med 2000;133:622-634.
6. Sullivan DH, Sun S, Walls RC. Protein-energy undernutrition among elderly hospitalized patients: A prospective study. JAMA 1999;281:2013-2019.
7. Sullivan DH, Walls RC. Impact of nutritional status on morbidity in a population of geriatric rehabilitation patients. J Am Geriatr Soc 1994;42:471-477.
8. Covinsky KE, Martin GE, Beyth R et al. The relationship between clinical assessments of nutritional status and adverse outcomes in older hospitalized medical patients. J Am Geriatr Soc 1999;47:532-538.
9. Sauvage LR Jr, Myklebust BM, Crow-Pan J et al. A clinical trial of strengthening and aerobic exercise to improve gait and balance in elderly male nursing home residents. Am J Phys Med Rehabil 1992;71:333-342.
10. Dempsey DT, Mullen JL, Buzby GP. The link between nutritional status and clinical outcome. Can nutritional intervention modify it? Am J Clin Nutr 1988;47:352-356.
11. Abernathy GB, Heizer WD, Holcombe BJ et al. Efficacy of tube feeding in supplying energy requirements of hospitalized patients. JPEN J Parenter Enteral Nutr 1989;13:387-391.
12. Fiatarone MA, O'Neill EF, Ryan ND et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994;330:1769-1775.
13. Headley S, Germain M, Mailloux P et al. Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis 2002;40:355-364.
14. Fielding RA, LeBrasseur NK, Cuoco A et al. High-velocity resistance training increases skeletal muscle peak power in older women. J Am Geriatr Soc 2002;50:655-662.
15. Sullivan DH, Roberson PK, Johnson LE et al. Effects of muscle strength training and testosterone in frail elderly males. Med Sci Sports Exerc 2005;37:1664-1672.
16. Yeh SS, Wu SY, Lee TP et al. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: Results of a double-blind, placebo-controlled study. J Am Geriatr Soc 2000;48:485-492.
17. Von Roenn JH. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia. Oncology 1994;51(Suppl 1):19-24.
18. Tchekmedyian NS, Hickman M, Siau J et al. Megestrol acetate in cancer anorexia and weight loss. Cancer 1992;69:1268-1274.
19. Lambert CP, Sullivan DH, Freeling SA et al. Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: A randomized controlled trial. J Clin Endocrinol Metab 2002;87:2100-2106.
20. Dempster P, Aitkens S. A new air displacement method for the determination of human body composition. Med Sci Sports Exerc 1995;27:1692-1697.
21. Siri WE. Body composition from fluid spaces and density. Analysis of methods. 1961. Nutrition 1993;9:480-491.
22. Sullivan DH, Wall PT, Bariola JR et al. Progressive resistance muscle strength training of hospitalized frail elderly. Am J Phys Med Rehabil 2001;80:503-509.
23. McDonagh MJ, Davies CT. Adaptive response of mammalian skeletal muscle to exercise with high loads. Eur J Appl Physiol 1984;52:139-155.
24. Phillips WT, Batterham AM, Valenzuela JE et al. Reliability of maximal strength testing in older adults. Arch Phys Med Rehabil 2004;85:329-334.
25. Reuben DB, Hirsch SH, Zhou K et al. The effects of megestrol acetate suspension for elderly patients with reduced appetite after hospitalization: A Phase II randomized clinical trial. J Am Geriatr Soc 2005;53:970-975.
26. Oster MH, Enders SR, Samuels SJ et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994;121:400-408.
27. Loprinzi CL, Schaid DJ, Dose AM et al. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 1993;11:152-154.
28. Mann M, Koller E, Murgo A et al. Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med 1997;157:1651-1656.
29. Bodenner DL, Medhi M, Evans WJ et al. Effects of megestrol acetate on pituitary function and end-organ hormone secretion: A post hoc analysis of serum samples from a 12-week study in healthy older men. Am J Geriatr Pharmacother 2005;3:160-167.
30. Goodman A, Cagliero E. Megestrol-induced clinical adrenal insufficiency. Eur J Gynaecol Oncol 2000;21:117-118.
31. Naing KK, Dewar JA, Leese GP. Megestrol acetate therapy and secondary adrenal suppression. Cancer 1999;86:1044-1049.
32. Subramanian S, Goker H, Kanji A et al. Clinical adrenal insufficiency in patients receiving megestrol therapy. Arch Intern Med 1997;157:1008-1011.
33. Lundgren S, Helle SI, Lonning PE. Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients. Clin Cancer Res 1996;2:1515-1521.
34. Geller J, Albert J, Yen SS et al. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol. J Clin Endocrinol Metab 1981;52:576-580.
35. Steer KA, Kurtz AB, Honour JW. Megestrol-induced Cushing's syndrome. Clin Endocrinol 1995;42:91-93.